← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
ESCO Technologies grew revenue, remained profitable, generated positive free cash flow at a 15.6% operating margin. Profit included material non-operating effects relative to operating margin, while free cash flow remained strong.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 19.2%OK
- Profitability — Net income grew 193.7% to $299.223M from $101.881MOK
- Cash flow — Free cash flow grew 107.1% to $205.617M from $99.267MOK
- Margins — Operating margin contracted 36 bps to 15.55%Watch
- Accounting — Profit included material non-operating effects relative to operating margin, while free cash flow remained strongNote
- Insiders — 0 purchases and 7 salesNote
Business
ESCO Technologies makes filtration, test and utility communication products.
Where the revenue comes from
Fiscal 2025, as ESCO TECHNOLOGIES INC reports it. History and quarterly detail are in the app.
- Aerospace And Defense$478.2M
- Utility Solutions Group$380.0M
- RF Shielding And Test$237.2M
Leadership changes
From ESCO TECHNOLOGIES INC's own filings, the day they're filed.
- James M. Stolze · Directors · departureeff. 2023-11-14
Latest filings
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-03
- 10-Q · Quarterly report2026-05-11
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ESCO TECHNOLOGIES INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.